Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ihsuan Tseng"'
Autor:
Ihsuan Tseng, Dashan Ai, Yun Chen, Hongcheng Zhu, Fangfang Li, Yang Xu, Lu Yu, Qi Liu, Jiaying Deng, Shengnan Hao, Zhengfei Zhu, Weixin Zhao, Min Fan, Ling Li, Fengtao Su, Kuaile Zhao
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-9 (2023)
Abstract Background Limited studies explored the relationship between lymphocyte recovery after definitive concurrent chemoradiotherapy (dCCRT) and prognosis in esophageal squamous cell carcinoma (ESCC). Methods ESCC patients with obtainable absolute
Externí odkaz:
https://doaj.org/article/d5607e29acd444c3bb287d4a5eec1d89
Autor:
Hongcheng Zhu, Zezhou Wang, Bingbin Deng, Miao Mo, Honggang Wang, Ke Chen, Haoxuan Wu, Ting Ye, Boyan Wang, Dashan Ai, Shennan Hao, Ihsuan Tseng, Kuaile Zhao
Publikováno v:
Thoracic Cancer, Vol 14, Iss 11, Pp 992-1003 (2023)
Abstract Background Esophageal cancer (EC) is a global health problem. Asia represents a huge burden of EC globally, and incidence and mortality vary considerably across different Asian regions. Methods Data on incidence, mortality, and preference we
Externí odkaz:
https://doaj.org/article/4ed6665f69604914b452e0a011ddc7f2
Autor:
Yun Chen, Zhengfei Zhu, Weixin Zhao, Qi Liu, Junhua Zhang, Jiaying Deng, Dashan Ai, Saiquan Lu, Liuqing Jiang, Ihsuan Tseng, Huixun Jia, Kuaile Zhao
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe optimal evidence-based management for the subsets of locally advanced esophageal squamous cell carcinoma (ESCC) patients who rejected or were intolerant to intravenous chemotherapy due to old age or serious comorbidities is currently la
Externí odkaz:
https://doaj.org/article/20f17a19649e4404b488008ef8b4cef7
Autor:
Bing Xu, Ihsuan Tseng, Xiaofei Zhang, Hui Chen, Eleonor Rivin del Campo, Jiaying Deng, Dashan Ai, Xumeng Fang, Xinchen Sun, Kuaile Zhao, Fengtao Su, Xiaolin Ge, Hongcheng Zhu
Publikováno v:
Journal of Thoracic Disease. 15:1805-1822
Autor:
Hongcheng Zhu, Zezhou Wang, Bingbin Deng, Miao Mo, Honggang Wang, Ke Chen, Haoxuan Wu, Ting Ye, Boyan Wang, Dashan Ai, Shennan Hao, Ihsuan Tseng, Kuaile Zhao
Publikováno v:
Thoracic Cancer. 14:992-1003
Autor:
Ihsuan Tseng, Yun Chen, Zhengfei Zhu, Weixin Zhao, Qi Liu, Junhua Zhang, Jiaying Deng, Dashan Ai, Saiquan Lu, Huixun Jia, Kuaile Zhao
Background: Concurrent chemoradiotherapy (CCRT) is a standard treatment for inoperable locally advanced esophageal carcinoma. However, there exists a group of patients who are intolerable to intravenous chemotherapy for the old age or with serious co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee0f74203e3c54585c08e4a973619d93
https://doi.org/10.21203/rs.3.rs-52559/v1
https://doi.org/10.21203/rs.3.rs-52559/v1